Category: 6. Health
-

Light and sound therapy dimming Alzheimer’s decline; AI coach matches humans in diabetes prevention; stillbirths more common than previously thought – Morning Medical Update
Light and sound show promise for dimming Alzheimer’s decline MIT researchers report that daily 40Hz light and sound stimulation — known as gamma entrainment using sensory stimuli (GENUS) — may slow cognitive decline and reduce biomarkers in… -
LUMOSA THERAPEUTICS ANNOUNCES POSITIVE RESULTS FROM LT3001(INTRAVENOUS ODATROLTIDE) PHASE 2B CLINICAL TRIAL IN ACUTE ISCHEMIC STROKE
- Results presented at the 17th World Stroke Congress (WSC 2025)
- LT3001(Odatroltide)-202 phase 2b study met primary endpoint. No symptomatic intracranial hemorrhage…
Continue Reading
-

Aptamer-Based Technique Flags Senescent Cells
When it comes to treating disease, one promising avenue is addressing the presence of senescent cells. These cells — also known as “zombie cells” — stop dividing but don’t die off as cells typically do. They turn up in numerous diseases,…
Continue Reading
-

E. coli in retail meat linked to thousands of urinary infections
Bacteria lurking in everyday store-bought meat may be causing thousands of urinary tract infections, especially in lower-income communities.
Study: Zoonotic Escherichia coli and urinary tract infections in Southern California. Image…
Continue Reading
-

Hereditary Hemochromatosis Type 2A Presenting With Hypogonadism, Diabetes, and Osteoporosis in a Young Woman
Ajeesh Thulaseedharan, Puthiyaveetil Khadar Jabbar, Sandra Mosses
JCEM Case Reports, Volume 3, Issue 10, October 2025, luaf148
https://doi.org/10.1210/jcemcr/luaf148Abstract
Hereditary hemochromatosis type 2A (juvenile hemochromatosis)…
Continue Reading
-

The Hypothalamic-Pituitary-Ovarian Axis, Ovarian Disorders, and Brain Aging
Heather Valera, Angela Chen, Kathryn J Grive
Endocrinology, Volume 166, Issue 10, October 2025, bqaf137
https://doi.org/10.1210/endocr/bqaf137Abstract
The hypothalamic-pituitary-ovarian (HPO) axis is a complex endocrine feedback…
Continue Reading
-
LUMOSA THERAPEUTICS ANNOUNCES POSITIVE RESULTS FROM LT3001(INTRAVENOUS ODATROLTIDE) PHASE 2B CLINICAL TRIAL IN ACUTE ISCHEMIC STROKE
- Results presented at the 17th World Stroke Congress (WSC 2025)
- LT3001(Odatroltide)-202 phase 2b study met primary endpoint. No symptomatic intracranial hemorrhage…
Continue Reading
-

Genomic characterization of carbapenem-resistant acinetobacter baumann
Introduction
Acinetobacter baumannii, a Gram-negative opportunistic pathogen, is a leading cause of hospital-acquired infections, frequently implicated in ventilator-associated pneumonia, bloodstream infections, and severe post-traumatic…
Continue Reading
-

Neuronal migration depends on blood flow in the adult mammalian brain
We focused on ghrelin, which can be delivered from the bloodstream to the brain parenchyma, including the OB tissue, by transcytosis across vascular walls (Rhea et al., 2018). In addition, a previous study showed that newly generated…
Continue Reading
-
Managing an Explosive outbreak of Cholera caused by multiple importations: One-Year experiences and lessons learnt | WHO
Op-Ed By Dr Humphrey Karamagi, WHO Representative for South Sudan
South Sudan is combating its largest and longest cholera outbreak since independence in 2011. The outbreak, which began in September 2024 has been sustained for now one year,…
Continue Reading